These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11558783)

  • 1. Parkin and Parkinson's: more than homonymy?
    Corti O; Brice A
    Ann Neurol; 2001 Sep; 50(3):283-5. PubMed ID: 11558783
    [No Abstract]   [Full Text] [Related]  

  • 2. The striatal dopaminergic deficit is dependent on the number of mutant alleles in a family with mutations in the parkin gene: evidence for enzymatic parkin function in humans.
    Hilker R; Klein C; Hedrich K; Ozelius LJ; Vieregge P; Herholz K; Pramstaller PP; Heiss WD
    Neurosci Lett; 2002 Apr; 323(1):50-4. PubMed ID: 11911988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linkage stratification and mutation analysis at the Parkin locus identifies mutation positive Parkinson's disease families.
    Nichols WC; Pankratz N; Uniacke SK; Pauciulo MW; Halter C; Rudolph A; Conneally PM; Foroud T
    J Med Genet; 2002 Jul; 39(7):489-92. PubMed ID: 12114481
    [No Abstract]   [Full Text] [Related]  

  • 4. [Parkin protein and molecular mechanism of Parkinson's disease].
    Imai Y
    Nihon Ronen Igakkai Zasshi; 2004 Nov; 41(6):619-21. PubMed ID: 15651375
    [No Abstract]   [Full Text] [Related]  

  • 5. Lewy bodies and parkinsonism in families with parkin mutations.
    Farrer M; Chan P; Chen R; Tan L; Lincoln S; Hernandez D; Forno L; Gwinn-Hardy K; Petrucelli L; Hussey J; Singleton A; Tanner C; Hardy J; Langston JW
    Ann Neurol; 2001 Sep; 50(3):293-300. PubMed ID: 11558785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The parkin gene is not involved in late-onset Parkinson's disease.
    Kann M; Hedrich K; Vieregge P; Jacobs H; Müller B; Kock N; Schwinger E; Klein C; Marder K; Harris J; Meija-Santana H; Bressman S; Ozelius LJ; Lang AE; Pramstaller PP
    Neurology; 2002 Mar; 58(5):835; author reply 835. PubMed ID: 11889262
    [No Abstract]   [Full Text] [Related]  

  • 7. Part I: parkin-associated proteins and Parkinson's disease.
    Dev KK; van der Putten H; Sommer B; Rovelli G
    Neuropharmacology; 2003 Jul; 45(1):1-13. PubMed ID: 12814656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of parkin in Parkinson's disease].
    Miklya I; Göltl P; Hafenscher F; Pencz N
    Neuropsychopharmacol Hung; 2014 Jun; 16(2):67-76. PubMed ID: 24978049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of parkin mutations in late-onset Parkinson's disease.
    Klein C; Hedrich K; Wellenbrock C; Kann M; Harris J; Marder K; Lang AE; Schwinger E; Ozelius LJ; Vieregge P; Pramstaller PP; Kramer PL
    Ann Neurol; 2003 Sep; 54(3):415-6; author reply 416-7. PubMed ID: 12953277
    [No Abstract]   [Full Text] [Related]  

  • 10. [Parkin, alpha-synuclein and other molecular aspects of Parkinson's disease].
    Corti O; Brice A
    J Soc Biol; 2002; 196(1):95-10. PubMed ID: 12134640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. alpha-Synuclein and parkin: coming together of pieces in puzzle of Parkinson's disease.
    Burke RE
    Lancet; 2001 Nov; 358(9293):1567-8. PubMed ID: 11716878
    [No Abstract]   [Full Text] [Related]  

  • 12. [A new point mutation on exon 2 of parkin gene in Parkinson's disease].
    Xu Y; Liu Z; Wang Y; Tao E; Chen G; Chen B
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Oct; 19(5):409-11. PubMed ID: 12362318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkin and Parkinson's disease.
    Mizuno Y; Hattori N; Mori H; Suzuki T; Tanaka K
    Curr Opin Neurol; 2001 Aug; 14(4):477-82. PubMed ID: 11470964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkin and Parkinson's disease: differentiated by non-dopaminergic dysfunction?
    Stoessl AJ
    Exp Neurol; 2010 Sep; 225(1):48-50. PubMed ID: 20450912
    [No Abstract]   [Full Text] [Related]  

  • 15. Functional association of the parkin gene promoter with idiopathic Parkinson's disease.
    West AB; Maraganore D; Crook J; Lesnick T; Lockhart PJ; Wilkes KM; Kapatos G; Hardy JA; Farrer MJ
    Hum Mol Genet; 2002 Oct; 11(22):2787-92. PubMed ID: 12374768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-synuclein and Parkinson's disease.
    Golbe LI
    Adv Neurol; 2003; 91():165-74. PubMed ID: 12442675
    [No Abstract]   [Full Text] [Related]  

  • 17. How do Parkin mutations result in neurodegeneration?
    Imai Y; Takahashi R
    Curr Opin Neurobiol; 2004 Jun; 14(3):384-9. PubMed ID: 15194120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etiology of Parkinson's disease: Genetics and environment revisited.
    Steece-Collier K; Maries E; Kordower JH
    Proc Natl Acad Sci U S A; 2002 Oct; 99(22):13972-4. PubMed ID: 12391311
    [No Abstract]   [Full Text] [Related]  

  • 19. Genetics of Parkinson's disease and biochemical studies of implicated gene products.
    Lansbury PT; Brice A
    Curr Opin Cell Biol; 2002 Oct; 14(5):653-60. PubMed ID: 12231362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease.
    Shimura H; Schlossmacher MG; Hattori N; Frosch MP; Trockenbacher A; Schneider R; Mizuno Y; Kosik KS; Selkoe DJ
    Science; 2001 Jul; 293(5528):263-9. PubMed ID: 11431533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.